MA40369A - Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil - Google Patents

Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil

Info

Publication number
MA40369A
MA40369A MA040369A MA40369A MA40369A MA 40369 A MA40369 A MA 40369A MA 040369 A MA040369 A MA 040369A MA 40369 A MA40369 A MA 40369A MA 40369 A MA40369 A MA 40369A
Authority
MA
Morocco
Prior art keywords
foods
drugs
preparation
cistanche tubulosa
ocular cells
Prior art date
Application number
MA040369A
Other languages
English (en)
Inventor
Chin-Wen Lee
Original Assignee
Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou filed Critical Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou
Publication of MA40369A publication Critical patent/MA40369A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection des cellules de l'œil. Ledit extrait permet aussi d'obtenir un médicament ou produit permettant de prévenir les maladies de l'œil ou retarder la progression des maladies de l'œil.
MA040369A 2014-07-03 2015-07-03 Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil MA40369A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462020409P 2014-07-03 2014-07-03

Publications (1)

Publication Number Publication Date
MA40369A true MA40369A (fr) 2017-06-21

Family

ID=55016238

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040369A MA40369A (fr) 2014-07-03 2015-07-03 Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil

Country Status (10)

Country Link
US (2) US20160000847A1 (fr)
EP (1) EP3181143B8 (fr)
JP (1) JP6573961B2 (fr)
KR (1) KR20170039160A (fr)
CN (2) CN105232640A (fr)
MA (1) MA40369A (fr)
MY (1) MY192535A (fr)
RU (1) RU2688939C2 (fr)
TW (1) TWI650131B (fr)
WO (1) WO2016000663A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6599505B2 (ja) 2018-04-27 2019-10-30 株式会社ダイヘン アークエンド調整装置、溶接システム、アークエンド調整方法及びコンピュータプログラム
KR20240042585A (ko) * 2021-05-06 2024-04-02 신파 티엔리 파머슈티컬 컴퍼니 리미티드 (항저우) 안구 건조증을 완화하기 위한 약품의 조제에서의 육종용 추출물의 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034169A1 (fr) * 1999-11-11 2001-05-17 Dietrich Paper Utilisation d'un extrait de plantago lanceolata
CN1268341C (zh) * 2003-03-04 2006-08-09 杏辉天力（杭州）药业有限公司 来源于管花肉苁蓉的含有苯乙醇苷的制剂及其制备方法和用途
JP4936507B2 (ja) * 2006-01-18 2012-05-23 学校法人近畿大学 カンカニクジュヨウの抽出物より得られる強壮剤又は強精剤、配糖体化合物及びそれらの用途
CN100475189C (zh) * 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
JP2008239505A (ja) * 2007-03-26 2008-10-09 Oriza Yuka Kk 神経芽細胞増殖促進剤及び神経突起伸展剤
JP5264107B2 (ja) * 2007-06-01 2013-08-14 小林製薬株式会社 抗酸化作用を有する組成物
CN101331906A (zh) * 2007-06-28 2008-12-31 杏辉天力（杭州）药业有限公司 含苁蓉成分和咖啡成分的饮品
CN101322750B (zh) * 2008-06-04 2012-01-04 张小平 管花肉苁蓉提取物的新用途
TWI486162B (zh) * 2010-06-16 2015-06-01 Sinphar Pharmaceutical Co Ltd 異類葉升麻苷或其醫藥學上可接受之鹽於抑制澱粉樣β肽生成、累積或聚集、以及製備預防或治療澱粉樣β肽相關疾病或狀況的藥物之用途
WO2012158591A1 (fr) * 2011-05-18 2012-11-22 The Research Foundation Of State University Of New York Produits et méthodes anti-blépharite
JP5969738B2 (ja) * 2011-07-25 2016-08-17 丸善製薬株式会社 抗糖化作用剤
CN103156867B (zh) * 2011-12-16 2019-04-30 杏辉天力（杭州）药业有限公司 预防或治疗淀粉样β肽相关疾病或状况的医药组合物
CN102813753B (zh) * 2012-05-22 2014-02-26 孟令刚 含有苁蓉或锁阳与菊花、牛磺酸、番茄红素、叶黄素、β-胡萝卜素组合的组合物
JP6151003B2 (ja) * 2012-10-26 2017-06-21 学校法人近畿大学 カンカニクジュヨウから得られる抗糖尿病剤、ヒト又は動物用医薬および機能性食品
US9339522B2 (en) * 2013-05-30 2016-05-17 Sinphar Pharmaceutical Co., Ltd. Method for regulating blood glucose level
CN103896997B (zh) * 2014-04-14 2016-07-06 青海伊纳维康生物科技有限公司 一种肉苁蓉中毛蕊花糖苷的分离纯化方法

Also Published As

Publication number Publication date
US20180117109A1 (en) 2018-05-03
JP2017531614A (ja) 2017-10-26
RU2688939C2 (ru) 2019-05-23
US10967029B2 (en) 2021-04-06
EP3181143B8 (fr) 2020-11-18
EP3181143B1 (fr) 2020-09-23
EP3181143A1 (fr) 2017-06-21
RU2017102407A (ru) 2018-08-03
RU2017102407A3 (fr) 2018-08-03
JP6573961B2 (ja) 2019-09-11
CN105232640A (zh) 2016-01-13
WO2016000663A1 (fr) 2016-01-07
KR20170039160A (ko) 2017-04-10
TWI650131B (zh) 2019-02-11
MY192535A (en) 2022-08-26
TW201601740A (zh) 2016-01-16
EP3181143A4 (fr) 2018-05-16
CN112870258A (zh) 2021-06-01
US20160000847A1 (en) 2016-01-07

Similar Documents

Publication Publication Date Title
IL285258A (en) Retinal ganglion cells and their progenitor cells
HK1245247A1 (zh) 溴结构域的抑制剂
EP3188688A4 (fr) Méthodes et compositions biocompatibles pour obtenir une libération prolongée de médicament dans l' il
EP3177732A4 (fr) Compositions et procédés pour le traitement de maladies et états pathologiques ophthalmiques
MY187540A (en) Compounds active towards bromodomains
EP3191022A4 (fr) Implants ophtalmiques avec profondeur de champ étendue et acuité visuelle à distance renforcée
EP3167046A4 (fr) Production et cryopréservation de cellules fucosylées à usage thérapeutique
EP3124741A4 (fr) Agent de soutènement auto-suspendu, sa préparation et son utilisation
EP3154533A4 (fr) Procédés d'anesthésie de tissu nerveux dans la voie du nerf trijumeau et utilisations médicales de ceux-ci
EP3220912A4 (fr) Combinaisons d'un inhibiteur de tlr et d'un inhibiteur de la tyrosine kinase de bruton
EP3102291A4 (fr) Progranuline (pgrn) et ses dérivés pour le diagnostic et le traitement de maladies lysosomales
AU365587S (en) Kettle
AU356247S (en) Coffee maker
EP3281539A4 (fr) Article de lingerie féminine et moyen de fixation
EP3238758A4 (fr) Hémodiafiltre et dispositif d'hémodiafiltration
PH12017501071B1 (en) Dihydropyrimidin-2-one compounds and medical use thereof
EP3246036A4 (fr) Medicament pour ameliorer l'etat de grossesse, et son utilisation
EP3167893A4 (fr) Compositions pharmaceutiques contenant un extrait de spirulina maxima en tant que principe actif pour la prévention et le traitement de maladies rétiniennes
PT3215143T (pt) Combinação compreendendo espirulina e palmitoíletanolamida
MA40369A (fr) Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil
EP3212280A4 (fr) Procédé d'adaptation aux acouphènes chez des patients à ic et à itc
EP3197466A4 (fr) Association de kynurénine et de cellules présentatrices d'antigène (cpa) en tant qu'agent thérapeutique, et méthodes d'utilisation de cette dernière dans la modulation immunitaire
EP3150584A4 (fr) Dérivé de 3,4-dihydroquinazoline et préparation complexe le contenant
EP3094330A4 (fr) Traitement de la maladie de crohn au moyen de faibles doses de laquinimod
HK1235660A1 (en) Methods and biocompatible compositions to achieve sustained drug release in the eye